Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Investor AB (publ)
  6. News
  7. Summary
    INVE A   SE0015811955


SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Investor : Patricia Industries' holding Atlas Antibodies acquires evitria, leader in recombinant antibody expression

07/28/2021 | 02:31am EDT

Atlas Antibodies, a leading provider of highly validated research antibodies, has signed an agreement to acquire evitria. evitria is a quality leader within custom recombinant antibody expression serving the biopharmaceutical industry. The acquisition brings together two highly innovative companies, with double digit organic growth over the last five years, to create an antibody-focused platform, serving a wide range of customers, with combined LTM adjusted EBITDA of approximately SEK 130m. Patricia Industries will contribute its 70 percent of Atlas Antibodies, with a reported book value of SEK 0.4bn, and approximately SEK 2.0bn of cash equity funding. Patricia Industries will hold approximately 90 percent of the combined company, which is expected to have net debt of approximately SEK 0.4bn.

"Within Patricia Industries we have built a number of great platform companies with leading market positions in attractive niches. To profitably grow these companies organically and through add-on acquisitions is a key priority for us. Going forward, we expect to continue to allocate significant capital to grow our companies", comments Investor President and CEO Johan Forssell.

Following the acquisition of evitria, Atlas Antibodies will be reported as a subsidiary within Patricia Industries.

"The combination of Atlas Antibodies and evitria creates a powerful platform, providing quality-leading antibodies to a wide range of customers including biopharmaceutical companies and academia. We see ample growth opportunities and look forward to working with the company to further develop the businesses", says Christian Cederholm, Head of Patricia Industries. "Atlas Antibodies has to date been reported as a financial investment. The vast majority of investments in this portfolio have been divested, resulting in more than 50 exits, and SEK 11bn of cash proceeds. In Atlas Antibodies, we see potential to build a unique platform around protein detection and analysis. The acquisition of evitria represents an important milestone on this journey."  

Closing is expected during the third quarter of 2021.

About Patricia Industries

Patricia Industries is a long-term owner that invests in companies and works to develop each company to its full potential. Patricia Industries is a part of the industrial holding company Investor AB, whose main owner is the Wallenberg Foundations.

About Atlas Antibodies
Atlas Antibodies is a leading, global developer of advanced reagents for biomedical research. The company originates from the Human Protein Atlas project and was founded in 2006 by researchers at the Royal Institute of Technology and Uppsala University. Atlas Antibodies is based in Stockholm, and is majority owned by Patricia Industries, a part of Investor AB.

About evitria
Founded in 2010 in Zurich, Switzerland, evitria is an expert provider of antibody expression services, with clients ranging from academic laboratories and small biotech start-ups to global biopharmaceutical companies. evitria is deeply specialized in CHO-based transient expression of antibodies, including bispecific and fusion antibodies, and other proteins.

For further information:

Viveka Hirdman-Ryrberg, Head of Corporate Communication and Sustainability, 
Phone +46 70 550 3500

Magnus Dalhammar, Head of Investor Relations, 
Phone +46 73 524 2130

Our press releases can be accessed at www.investorab.com

Investor, founded by the Wallenberg family in 1916, is an engaged owner of high quality global companies. We have a long-term investment perspective. Through board participation, as well as industrial experience, our network and financial strength, we work continuously to support our companies to remain or become best-in-class. Our holdings include, among others, ABB, Atlas Copco, Ericsson, Mölnlycke and SEB.



(c) 2021 Cision. All rights reserved., source Press Releases - English

Stocks mentioned in the article
ChangeLast1st jan.
ATLAS COPCO AB 0.71% 566.6 Delayed Quote.33.60%
INVESTOR AB (PUBL) 0.34% 193.7 Delayed Quote.29.24%
All news about INVESTOR AB (PUBL)
09/13Husqvarna AB's Nomination Committee for the 2022 Annual General Meeting
09/13INVESTOR AB : 's Nomination Committee for the 2022 Annual General Meeting
09/07INVESTOR : Patricia Industries funds strategic add-on acquisition by Sarnova
09/02INVESTOR : supports Agnafit Bidco's bid for Sobi
08/05Investor's Patricia Industries to Fund $240 Million Acquisition of Biopharm Tech Firm S..
08/05INVESTOR : Patricia Industries to fund strategic add-on acquisition by Advanced Instrument..
07/28INVESTOR : Patricia Industries' holding Atlas Antibodies acquires evitria, leader in recom..
07/15GLOBAL MARKETS LIVE : Daimler, Morgan Stanley, Microsoft, Avast, AMC Entertainment...
07/15INVESTOR : Sweden's Investor AB Logs H1 Earnings Surge
07/15Investor AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021
More news
Sales 2021 38 682 M 4 446 M 4 446 M
Net income 2021 47 971 M 5 514 M 5 514 M
Net Debt 2021 12 281 M 1 412 M 1 412 M
P/E ratio 2021 6,27x
Yield 2021 1,95%
Capitalization 594 B 68 620 M 68 263 M
EV / Sales 2021 15,7x
EV / Sales 2022 15,8x
Nbr of Employees 13 964
Free-Float 99,8%
Duration : Period :
Investor AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INVESTOR AB (PUBL)
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 193,70 SEK
Average target price 210,33 SEK
Spread / Average Target 8,59%
EPS Revisions
Managers and Directors
Johan Patrik Lennart Forssell President, Chief Executive Officer & Director
Helena Ildiko Saxon Chief Financial Officer & Member-Management Group
Jacob Wallenberg Chairman
Petra Hedengran General Counsel & Head-Compliance
Grace Reksten Skaugen Independent Director
Sector and Competitors
1st jan.Capi. (M$)
INVESTOR AB (PUBL)29.24%68 237
HAL TRUST31.27%15 358
LIFCO AB (PUBL)57.67%12 985